When most people think about schizophrenia, they think about hallucinations or delusions—voices that aren’t there or beliefs that don’t align with reality. These symptoms are often grouped under the ...

The study met its primary endpoint demonstrating a significant reduction in experiential negative symptoms with CT-155. For patients with schizophrenia experiencing negative symptoms, the addition of ...

Panelists discuss how digital therapeutics could address the enormous unmet need for treating negative symptoms in the 60% of patients with schizophrenia who experience them, potentially reducing ...

MIAMI — Recent clinical trials on the use of herbal and nutraceutical agents as adjunctive treatment for schizophrenia show that these agents have some benefit in alleviating the negative symptoms of ...

Panelists discuss how negative symptoms create significant patient burden by appearing during the prodromal period in late adolescence and requiring a comprehensive biopsychosocial treatment approach ...